The Enterprise Value as of December 2025 (TTM) for Ocuphire Pharma, Inc. (OCUP) is 129.57M

According to Ocuphire Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 129.57M. This represents a change of 745.35% compared to the average of 15.33M of the last 4 quarters.

Ocuphire Pharma, Inc. (OCUP) Historical Enterprise Value (quarterly & annually)

How has OCUP Enterprise Value performed in the past?

The mean historical Enterprise Value of Ocuphire Pharma, Inc. over the last ten years is -3533861.03. The current 129.57M Enterprise Value has changed -366763.53% with respect to the historical average. Over the past ten years (40 quarters), OCUP's Enterprise Value was at its highest in in the June 2025 quarter at 27.28M. The Enterprise Value was at its lowest in in the December 2023 quarter at -22742476.85.

Ocuphire Pharma, Inc. (OCUP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ocuphire Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ocuphire Pharma, Inc. (OCUP) Average Enterprise Value

How has OCUP Enterprise Value performed in the past?

The current Enterprise Value of Ocuphire Pharma, Inc. (OCUP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ocuphire Pharma, Inc. (OCUP) Enterprise Value vs. Peers

How is OCUP’s Enterprise Value compared to its peers?

Ocuphire Pharma, Inc.’s Enterprise Value is greater than Grace Therapeutics, Inc. (30.42M), greater than Marinus Pharmaceuticals, Inc. (44.18M), greater than Lunai Bioworks Inc. (35.00M), greater than Angion Biomedica Corp. (14.84M), greater than Allakos Inc. (5.52M), greater than LianBio (-41662245.00), greater than Liminal BioSciences Inc. (2.37M), greater than Freeline Therapeutics Holdings plc (-13071904.00), less than Oruka Therapeutics, Inc. (1.04B), greater than Serina Therapeutics, Inc. (27.42M),

Build a custom stock screener for Ocuphire Pharma, Inc. (OCUP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocuphire Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ocuphire Pharma, Inc. (OCUP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ocuphire Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.